Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.


Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
12/06/17Charles River Adds ERS License to CRISPR/Cas9 Service OfferingPrinter Friendly Version
11/28/17Charles River Announces Success of Integrated Discovery Project with ENYO PharmaPrinter Friendly Version
11/09/17Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing OperationsPrinter Friendly Version
11/01/17Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017Printer Friendly Version
View More

Upcoming Events

There are currently no events scheduled.
View More

Stock Quote

CRL (common)
Price
$104.88
Change (%)
- 1.12 (1.06%)
Volume
300,979
Exchange
NYSE
Data as of 12/14/17 4:02 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)